Abstracts Coronavirus disease 2019 (COVID-19) emerged as a pandemic that spread
rapidly around the world, causing nearly 500 billion infections and more than 6 million …

This scoping review aimed to explore the prevalence and patterns of global antibiotic use
and bacterial infection in COVID-19 patients from studies published between June 2020 and …

Background There are many pharmacologic therapies that are being used or considered for
treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated …

Nowadays, searching for new anti-infective agents with diverse mechanisms of action has
become necessary. In this study, 16 pyrazole and pyrazolo [1, 5-a] pyrimidine derivatives …

Background There are limited US data assessing adherence to surgical antimicrobial
prophylaxis guidelines, particularly across a large, nationwide sample. Moreover, commonly …

The enormous burden of the COVID-19 pandemic in economic and healthcare terms has
cast a shadow on the serious threat of antimicrobial resistance, increasing the inappropriate …

Background Empiric antibiotic use among hospitalized adults in the United States (US) is
largely undescribed. Identifying factors associated with broad-spectrum empiric therapy may …

There are many pharmacologic therapies that are being used or considered for treatment of
coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence …

The COVID-19 pandemic has significantly influenced antimicrobial use in hospitals, raising
concerns regarding increased antimicrobial resistance (AMR) through their overuse. The …

Importance Antibiotic stewardship for asymptomatic bacteriuria (ASB) is an important quality
improvement target. Understanding how to implement successful antibiotic stewardship …